Mankind Pharma Limited has announced that Mr. Bharat Anand has completed his second term as an Independent Director on August 30, 2026. Consequently, he has ceased to be a director of the company and a member of its Audit, Nomination and Remuneration, Risk Management, and Corporate Social Responsibility Committees. The company expressed sincere appreciation for his contributions.
Independent Director Departs After Term Completion
Mankind Pharma Limited has formally notified exchanges that Mr. Bharat Anand (DIN: 02806475) has concluded his tenure as an Independent Director. His second term officially ended on August 30, 2026, marking his cessation from the board. This development comes as per the company’s standard governance procedures and the completion of his mandated service period.
Committee Memberships Conclude
Following his departure from the board, Mr. Anand has also stepped down from his roles as a member of several key board committees. These include the Audit Committee, the Nomination and Remuneration Committee, the Risk Management Committee, and the Corporate Social Responsibility Committee. The company has provided details as per SEBI regulations.
Appreciation for Service
The Board of Directors and the management of Mankind Pharma Limited conveyed their gratitude for the significant contributions, guidance, and support provided by Mr. Bharat Anand during his association with the company as an Independent Director. The formal communication also includes a table detailing the change as required by listing regulations.
Source: BSE
